D-1376-2020 Class III Terminated
FDA drug recall D-1376-2020 was initiated by Flexion Therapeutics, Inc. on May 19, 2020 and is designated Class III. Reason for recall: Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded The recall status is terminated (terminated Nov 3, 2020). Affected quantity: 792 kits.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 8, 2020
- Initiation Date
- May 19, 2020
- Termination Date
- Nov 3, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 792 kits
Product description
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01
Reason for recall
Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded
Distribution pattern
Nationwide within the United States only lots distributed by Besse Medical are affected.
Code information
Lot #: ZA19014, exp. date 05/2021 Only the specific lot distributed by Besse Medical are affected.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1376-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026